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Abstract
The structures of the spinal cord and vertebral column are designed to provide flexibility,
while still providing ample protection for the spinal cord deep within. While it does offer
remarkable protection against most routine trauma, the spinal cord is still vulnerable to
high-force etiologies of trauma and may become damaged as a result. These events are
referred to as primary injury. Following the initial injury, the body’s own physiological
responses cause a cascade of deleterious effects, known as secondary injury. Secondary
injury is a major therapeutic target in mitigating the effects of spinal cord injury (SCI),
and much research is currently being done to develop more effective treatment options.
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Spinal Cord Trauma: An Overview of Normal Structure and Function, Primary and
Secondary Mechanisms of Injury, and Emerging Treatment Modalities

Spinal cord injury is a devastating condition that affects over a quarter of a
million individuals in the U.S. alone, with up to 500,000 new cases occurring worldwide
each year [1, 2]. While the cause of spinal cord injury (SCI) can be due to disease-related
mechanisms, the World Health Organization estimates that around 90% of cases are
attributable to trauma-related etiologies [2]. SCI is a complex disorder that can result in a
plethora of different outcomes depending on the site and severity of the traumatic insult,
the promptness and efficacy of acute and sub-acute phase treatment, and the success of
therapy efforts. Manipulation of just one of these variables can potentially have an
enormous influence on long-term prognosis.
Normal (Physiological) Spinal Cord Structure & Function
The spinal cord itself is a masterpiece of engineering, massively intricate and
complicated in both structure and function. Fundamentally, it can be thought of as a very
large bundle of nerves, extending from the medulla oblongata portion of the brainstem
and traversing the superior two thirds of the vertebral canal before terminating in the
conus medullaris between the levels of T12 and L3 [3, 4]. Together with the brain, it
comprises the central nervous system (CNS), and serves to connect the brain to the rest of
the body. It is made up of numerous tracts, that is, smaller neural bundles each with a
more narrow purpose [4]. Some of these spinal tracts bring information from the brain to
the peripheral nervous system (PNS)—these are called descending tracts, while other
tracts carry information from the periphery to the brain—these are referred to as
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ascending tracts [4]. These pathways are analogous to a super-highway, with various
lanes going in both directions, each with its own destination and purpose, and yet
collectively integrated into one comprehensive structure.
As with any highway, the spinal cord also contains exits. At the level of each
vertebrae, a pair of spinal nerves emanate from the cord which provide innervation and
communication for the somatic structures at that level [3]. These step-wise regions of
innervation are called dermatomes in reference to the skin and myotomes in reference to
muscle tissue [3]. When these spinal nerves become impinged or severed, partial or
complete paralysis and loss of sensation occurs in the tissues relying exclusively on that
source of innervation. As we will discuss later on, trauma to the spinal cord itself can
result in paralysis and loss of sensation in the entirety of the body inferior to the lesion
location.
In light of this complex organization, it is easy to see just how devastating, and
strangely enigmatic, damage to the spinal cord can be. But the spinal cord is not an easy
structure to injure, as it has multiple layers of defense that protect it from damage in most
physiological contexts.
Normal (Physiological) Vertebral Column Structure
While the spinal cord itself is relatively delicate, it possesses an exceptionally
protective surrounding structure in the various components of the vertebral column.
These structural elements envelope the spinal cord in many layers of reinforcement and
prevent damage from occurring as a result of day-to-day wear and tear. Immediately
surrounding the cord are the spinal meninges. These meninges arise in three layers (from
innermost to outermost): the pia mater, the arachnoid mater, and the dura mater [3]. They
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provide a tri-layer connective tissue sheath that runs the length of the cord [3]. The pia
mater is the deepest layer, an exceedingly thin membrane that directly encapsulates the
spinal cord throughout its length [3]. Just superficial to the pia mater is the arachnoid
mater. The arachnoid is avascular and made up of fibrous and elastic tissue [3]. Between
the pia and arachnoid is the subarachnoid space [3]. The subarachnoid space is an
additional protective feature. It is filled with cerebrospinal fluid (CSF), which cushions
the entire CNS system, isolating it from injury by absorbing exogenous traumatic forces
[5].
Continuing out from the arachnoid mater, the superficial-most layer of the
meninges is the spinal dura mater. The spinal dura is a continuation of the cranial dura
mater, which covers the brain, and serves as its spinal counterpart [3]. It originates
superiorly at the foramen magnum of the cranium and lines the entire interior of the
vertebral canal [3]. In this way, it forms a sort of membranous capsule around the spinal
cord, portions of the spinal roots, and the deeper meningeal layers, and is referred to in
this regard as the spinal dural sac [3]. The dura mater membrane has a tougher, more
fibrous composition than the deeper meninges, and provides a resilient outer jacket for
the spinal cord itself [3]. Surrounding the dura mater is a layer of epidural fat [3].
Together, the spinal meninges, the CSF contained within, and the epidural fat layer
provide the deepest line of defense for the spinal cord amongst the structures of the
vertebral column.
The vertebral column itself is designed with spinal cord protection as a primary
consideration. Each vertebra (especially those in the thoracic and lumbar regions)
features a relatively large, rounded body, which fulfills the majority of the weight-bearing
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component of the bone’s responsibility [3]. This ensures that the spinal cord will be
subjected to minimal compressive force, as the bulk of these compressive forces will be
borne by the vertebral bodies. Furthermore, extending posteriorly from the body of each
vertebra is a thick semilunar band of bone called the vertebral arch [3]. Together, this
arch and the posterior aspect of the vertebral body combine to form the walls of the
vertebral foramen [3]. The vertebral foramina of all the vertebrae, taken together, make
up the vertebral canal. In addition to the protection afforded by the vertebral arch, the
vertebral foramen is further reinforced to the posterior by the spinous process of the
vertebra, and on the lateral aspects by the transverse processes of the vertebra [3]. All of
these bony features defend the spinal cord from penetrating and blunt forms of trauma.
Lastly, the articular processes of the vertebrae interact with one another in such a way as
to positively limit the flexibility of the spine and promote the maintenance of its
alignment [3]. The limitations imposed by these articular processes protect the spinal
cord from being placed in positions where it is subjected to excessive bending and
twisting forces [3].
Beyond this, surrounding the vertebrae are various ligaments that increase the
protective capacity of the vertebral column even further. The anterior longitudinal
ligament can be found running along the anterolateral aspect of the vertebral column,
where it limits spinal hyperextension [3]. Its counterpart, the posterior longitudinal
ligament traverses the posterior surface of the vertebral bodies within the vertebral canal
[3]. In addition to these, other ligaments, such as the ligamenta flava and supraspinous
ligaments, serve to reinforce the joints between individual vertebrae [3]. The combined
effect of these structures helps protect the spinal cord from tensile and sheering forces.
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Finally, we come to the muscular layers of protection. While a comprehensive
examination of the musculature of the back is beyond the scope of this thesis, the system
can be understood in an elementary way as consisting of intrinsic (deep) muscles and
extrinsic (superficial) muscles [3]. The deep muscles of the back have various functions.
While some of them, chiefly the muscles of the erector spinae group, have dynamic
function, many of the other, smaller muscles have a more postural and proprioceptive
function [3]. The extrinsic muscles of the back, such as the trapezius group, latissimus
dorsi, and the rhomboids, are not spinal muscles, proper, but instead perform dynamic
actions in the posterior region of the body [3]. Regardless of their particular function,
however, all of these muscles and their associated fascia provide an additional layer of
support and protection for the spine and, together, serve to shield the vertebral column
from external sources of trauma by absorbing shock and excessive forces on a superficial
level [3].
All things considered, from the pia mater to the superficial fascia of the back, the
spinal cord is remarkably well-defended from injury by a diverse and numerous set of
protective structures. It is this set of protective structures which keeps us safe from injury
on a daily basis; despite the many trips, falls, and bumps we experience in our lifetime,
relatively few of us will ever suffer remarkable neurological consequences. With that
being said, however, these protective structures are not impervious; if and when they are
subjected to extreme mechanisms of trauma they may be breached, exposing the
vulnerability of the spinal cord within. In the next section, we will briefly explore what is
termed primary injury, the initial traumatic insult to the spinal cord tissue.
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Primary Injury: An Overview
Any given spinal cord injury is really a composite of two types of injury: primary
injury and secondary injury. As was mentioned above, primary injury refers to the initial
damage incurred in the acute trauma event—it is probably what most people would think
of when presented with the concept of spinal cord injury. Secondary injury, which will be
the focus of much of this thesis, is as much a disease process as it is a mechanism of
injury. It refers to the cumulative deleterious effects of the body’s physiological
responses to primary injury, which result in lesion expansion and exacerbation of
functional losses. For clinical purposes, secondary injury is actually a much more
relevant topic to study [6]. After all, very little can be done in immediate response to
primary injury—in most cases it happens instantaneously, and by the time emergency
services personnel arrive little can be done to alleviate it [6]. There are a few exceptions
to this, including cases where surgery is required to remove a primary injury implement,
such as is the case with some combat-related wounds, but for the most part, primary
injury is not a feasible target for treatment [6].
Nevertheless, despite the fact that primary injury is the less clinically-significant
subject, it is essential to developing a full understanding of SCI as a whole. Primary
injury severity is the single greatest predictor of overall SCI prognosis and discerning the
mechanism of primary injury in any given case is an important consideration for
clinicians seeking to develop a treatment protocol in the emergency setting. Therefore we
will give the topic of primary injury a brief treatment as a part of this thesis. For a much
more detailed look at primary injury mechanisms, see the article, Mechanism and
pathophysiology of spinal and spinal cord injury (Braakman, 1991).
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In terms of primary injury causation, data from The National Spinal Cord Injury
Statistical Center (NSCISC) lists “Vehicular Accidents” as the most common cause of
SCI, contributing 39.08% of all cases [7]. This is followed by “Falls” at 29.54% of cases,
“Violence” at 14.41% of cases, and “Sports and Recreation” at 8.39% of cases [7]. It is
perhaps notable that the number one single cause, automobile accidents, has only existed
since the invention of the automobile in the late 1800’s [8]. Looking at these common
causes should serve to underscore the fact that SCI is actually not at all easy to do. On the
contrary, overcoming the built-in defenses of the vertebral column requires a tremendous
amount of force directed at the spine; force that can typically only be amassed in vehicles
or through falls, sports collisions, or violence.
Just as we have reviewed a brief primer in SCI causation, we will now delve into
a cursory look at SCI mechanism. When discussing vertebral column structure above,
several different types of forces were mentioned which come into play as we look at the
essential mechanisms of spinal trauma. Iencean (2003), describes them more
comprehensively in the following in four ways: 1. Axial deformation, 2. Torsion or axial
rotation, 3. Segmental translation, including shearing version, and 4. Combined
mechanism, simultaneous or successive [9].
The first of these is axial deformation. This essentially means a disruption to the
structure of the spinal cord in the axial plane. This takes in both compression of the spinal
cord and elongation of the spinal cord. Iencean continues to break both of these down
further into centric and eccentric variations [9]. Centric compression refers to
compression in a directly axial plane, causing forced shortening of the spinal cord [9].
Centric elongation refers to stretching of the spinal cord in a directly axial plane, also
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referred to as distraction [9]. The eccentric forms of these mechanisms refer to instances
where compression and/or elongation occur in conjunction with bending trauma. To
illustrate this, imagine what happens when you attempt to bend a metal rod. Inevitably,
the aspect of the rod on the side of the bend will experience compression, while the side
opposite the bend will likely experience some degree of elongation. This same principal
applies to the spinal cord in instances when it is subjected to bending forces that exceed
physiological parameters (such as in cases of hyperflexion and hyperextension). At the
location where the trauma was sustained, part of the cord will experience some
compression, or crushing, while the opposite face will exhibit some elongation, or
stretching, with the overall degree of axial deformation varying based on the intensity of
the injury [9].
The second essential mechanism of spinal trauma described by Iencean is torsion,
or axial rotation [9]. This occurs in conjunction with twisting injuries, where the spinal
cord is rotated beyond its physical limits, often associated with catastrophic damage to
the bony structures of the spinal column [9]. The third type of trauma outlined is
segmental translation [9]. Segmental translation occurs when opposing forces are exerted
on two or more sequential vertebrae, causing them to slide across one another in opposite
directions. This process results in the pinching off of the interior of the vertebral canal
and often results in severe acute damage to the spinal cord [9].
The final class of mechanism Iencean describes is the combined mechanism, in
which traumatic forces result in a mechanism pattern which includes, to some extent,
components of two or more of the mechanisms described above [9]. In this way, the
combined mechanism can practically be understood as a complex comprised of a set of
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more simple mechanisms, which may all occur simultaneously in one instant or may
present sequentially to one another [9]. Due to the intense, unpredictable nature of many
SCI etiologies, Iencean states that the combined mechanism is the trauma mechanism
most commonly observed in real-life cases [9]. Understanding each of these mechanisms
and the plethora of ways they can compound upon each other is helpful in classifying and
grading spinal cord insults in the clinical setting.
The other primary factors of consideration in primary spinal cord injury are the
site and severity of the insult. Site is critical; since nervous function is affected
throughout the entirety of the body below the point of trauma, damage at inferior levels
of the spine conserves more function and sensation than damage at superior levels.
Trauma in much of the cervical spine, for example, often results in quadriplegia—
paralysis in all four limbs, while trauma below the cervical spine often results in
preserved upper limb function, referred to as paraplegia [10]. As a general rule, in cases
where mechanism and completeness of the lesion is the same, lower lesion location
results in more favorable outcomes in terms of conserved function and reduced morbidity
[10].
The last piece of primary injury which we will cover is the severity, also referred
to as the completeness, of the injury. Incomplete injuries are characterized by lesions
which do not completely impede the passage of impulses between the brain and
periphery. Individuals in these cases often spontaneously regain some level of function
below the level of injury and usually are more responsive to physical therapy efforts [10].
Individuals who experience complete or nearly complete injury are much less likely to
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spontaneously regain significant function and have a poorer prognosis, even with
rigorous therapy [10].
Together, these primary injury characteristics—cause, mechanism, site, and
completeness—form an objective picture of spinal cord injury. By piecing together an
accurate history of the injury event and using radiology to image the trauma site,
practitioners can glean a fairly comprehensive understanding of the injury. This is useful
in preliminary classification of the injury and can help with forming an appropriate
treatment plan in the acute and early sub-acute phases of the injury process. As time goes
on, however, practitioners shift to a more standardized measure of SCI severity, a
universal classification scale known as the International Standards of Neurologic
Classification of Spinal Cord Injury (ISNCSCI) [10]. The ISNCSCI is a testing protocol
published by the American Spinal Injury Association (ASIA) that measures sensory and
motor function throughout the body through a numerical scoring system that classifies the
injury quantitatively [10, 11]. This evaluation protocol is typically conducted seven to ten
days post-injury, with the intent of allowing sufficient time for physiological responses to
stabilize [10].
Secondary Injury: An Overview
Now that we have laid the foundation of understanding primary injury more
clearly, we can begin to delve into deeper exploration of secondary injury. Secondary
injury, as we have already defined above, consists of the cumulative deleterious effects of
the body’s physiological responses to primary injury [6, 10]. In other words, the
incidence of a primary injury initiates a cascade of physiological responses at and around
the site of the traumatic lesion. Some of these responses are beneficial to the healing
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process, but many of these responses only serve to cause further damage. Deleterious
secondary injury processes exacerbate nervous tissue death, further expanding the lesion
and resulting in increased functional losses, ultimately leading to a poorer prognosis
overall [6, 10]. The remainder of this thesis will focus on these secondary injury
processes, with a special emphasis on two key mechanisms, their biochemical
backgrounds, and current research in therapies to mitigate their effects. We will conclude
with a look forward to the promising field of multi-modal therapy, which seeks ways to
maximize optimal outcomes by targeting multiple secondary injury mechanisms at once.
There are many different modalities of secondary injury. One source lists up to 25
individual contributing mechanisms [6]. These processes begin within seconds of the
injury event, and may continue, to some degree, for months following onset [6]. While all
twenty-five mechanisms are contributing factors, six of these mechanisms have been
highlighted by the National Institute of Neurological Disorders and Stroke in their
feature, Spinal Cord Injury: Hope Through Research [10]. Namely, they are: changes in
blood flow and leaky vasculature in and around the injury site; inflammation due to
overactive immune response; spontaneous apoptotic pathway/demyelination; scarring of
injury site due to glial cell activity; toxic release of neurotransmitters from damaged cells,
especially glutamate; and, lastly, free radical chain reaction [10]. Together, these
physiological processes contribute significantly to the exacerbation of neuronal damage
following primary injury. The first four of these mechanisms will be given a brief
discussion, in order to convey a working understanding of their biochemical and cellular
basis, while the final two will be featured in more depth, with a short analysis of research
in these areas.
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Secondary Injury Mechanism 1: Blood flow and vascular leakage
Disruption of the spinal cord vasculature begins with primary injury [12]. Trauma
to the affected region causes damage to the microvasculature in that immediate region,
resulting in both local bleeding (hemorrhage) as well as reduced perfusion (ischemia) [6,
12]. This reduced perfusion may be attributed to either clotting or vasospasm in the
damaged microcirculation [6]. Secondary to this vascular damage, edema has been noted
to develop, which puts further pressure on the damaged region and exacerbates
detrimental effects [6, 10]. All of these disease processes cause necrosis of cells
surrounding the immediate site of trauma, and cause expansion of the lesion within the
first several-to-48 hours following injury [6, 10, 12]. It is also important to realize that
these vascular disruptions also fundamentally affect the blood-spinal cord barrier
(BSCB). The deterioration of this barrier stems, on a cellular level, from the disruption of
the endothelial cells, pericytes, and astrocytes surrounding the spinal microvasculature
[12]. In a normal physiological context, these cells protect and nourish the neural tissue,
and breaking the barrier thus results in a two-fold negative effect. On one hand, it
exposes the neural tissue to harsh blood-borne molecules that accelerate necrosis, and on
the other hand it causes the neural tissue to starve due to lack of available nutrients [12].
Secondary Injury Mechanism 2: Inflammation due to immune cell infiltration
In a normal physiological state, somatic immune cells are restricted from entering
the CNS by the blood-CNS barrier. With this barrier broken, as has just been discussed,
these immune cells are no longer prohibited access to the spinal cord and begin to
infiltrate the injury site in large numbers [6, 10]. This begins with neutrophils, followed
by monocytes, which develop into macrophages. While these cells produce some positive
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effects, they also contribute considerably to the negative secondary injury process by
causing a rapid escalation of inflammation.
These cells release various cytokines, including inflammatory interleukins, as
well as other pro-inflammatory molecules and byproducts, which ramp up recruitment of
additional immune cells and cause the wholesale activation of inflammatory pathways in
the region surrounding the lesion [6, 10, 13] These upregulated cytokines include tumor
necrosis factor (TNF) –α, interleukin (IL)-6, and IL-1. The combined effect of these
processes cause the large-scale death of neurons not originally affected in the initial
trauma [6, 10].
Secondary Injury Mechanism 3: Apoptosis/Demyelination
In a poorly-understood response to the influx of non-nervous immune cells and
the upregulation of inflammatory cytokines, neurons and oligodendrocytes in the general
vicinity of the lesion have been observed to undergo apoptosis in the acute and sub-acute
phases following the primary injury [6, 10, 13]. This process is typically associated with
an intracellular influx of the Ca2+ ion, an explanation which makes sense in the cells
immediately surrounding the lesion site [6, 13]. Oddly, however, apoptosis is also
observed to occur in neurons and oligodendrocytes further away from the injury locus,
beyond the range of any influence from the localized spike in calcium [6]. It is theorized
that apoptosis in these cells may be stimulated by other components of the secondary
injury process [6].
In addition to apoptosis, progressive demyelination has also been observed in the
vicinity of the lesion [6, 10]. This occurs secondarily to the apoptosis of oligodendrocytes
described above, as it is these oligodendrocytes which provide the myelin sheath [6, 10].

SPINAL CORD TRAUMA

17

Loss of these cells results in the deterioration of the myelin covering in surviving
neurons, which exposes them to free radical degradation, inflammatory damage, etc. [6].
Destruction of these exposed axons is a major contributing factor to the progressive loss
of communicative patency along the spinal cord in the sub-acute phase [6, 13].
Secondary Injury Mechanism 4: Astroglial scarring
In the period following SCI, reactive astrocytes begin to congregate on the
margins of the spinal cord lesion [10, 14]. These astrocytes undergo hypertrophy and
proliferation to create a dense fibrous network, separating the damaged region from the
healthy regions of tissue [14, 15]. In so doing it re-establishes the BSCB and protects the
healthy tissue regions from further degradation [16]. This is very beneficial effect in the
short-term, but it leads to difficulties in the long term [10, 14, 16-17]. As acute processes
stabilize, this astroglial scar prevails, and has been shown to impede the regrowth of
axons back through the lesion site, leading to the inhibition of functional recovery [10,
16, 17].
Secondary Injury Mechanism 5: Glutamate excitotoxicity
Mechanism
Finally, it is time to take a deeper look at two of the key mechanisms of secondary
injury. The first of these is glutamate excitotoxicity. Glutamate is an excitatory
neurotransmitter that has a major role in the CNS [6, 18, 20]. In normal physiological
states, it can be found in storage vesicles at the axon terminal, and in transientlyoccurring, minute amounts within the synaptic cleft [18, 20]. When released, glutamate
stimulates various receptors on the target neuron. There are a few classes of cell-surface
receptors that respond to glutamate. The first three are referred to as ionotropic receptors,

SPINAL CORD TRAUMA

18

these are the N-methyl-d-aspartate receptor (NMDA), the kainic acid (KA) receptor, and
the α-amino-3-hydroxy-5-methyl-4-isoxazole proprionate receptor (AMPA) [20]. The
fourth class of glutamate receptor is the metabotropic glutamate receptor, a G-protein
coupled class of receptor that mediates downstream processes [20]. While glutamate is an
extremely potent neurotransmitter, it does not typically spend much time in the synapse,
as it is rapidly taken up by glutamate transporters in the surrounding neural and glial cells
following its release [18, 20]. This moderates the duration for which the target neuron is
under the influence of glutamate and prevents the accumulation of glutamate in the
synaptic cleft [18, 20].
In SCI conditions, various processes cause an excessive release of glutamate into
the extracellular space. Necrosis of damaged cells causes spillage of glutamate stores into
the surrounding extracellular fluid, and ion gradient fluctuations resulting from other
secondary injury mechanisms can reverse the action of glutamate transporter proteins,
such that the very transporters that are supposed to remove glutamate from the
extracellular space actually cause the release of additional neurotransmitter [18, 20]. As
these drastically excessive glutamate levels remain unchecked, the neurotransmitter
diffuses through the extracellular space, causing indiscriminate and constant stimulation
of all cells with glutamate receptors in that region of tissue [18-20]. Especially at risk are
cells with high numbers of NMDA and AMPA receptors, which include neurons and
oligodendrocytes [6, 20]. These cells receive a deadly amount of excitatory stimulation.
This stimulation causes the opening of cation channels, resulting in an influx of Ca2+ ions
which initiate a feedforward response which brings about the rapid death of the cell [6,
18-20].
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Therapeutic Targets
There are currently two major avenues of therapy thought to combat glutamate
excitotoxicity. The first involves the use of glutamate receptor antagonists [6, 20]. These
compounds act by binding competitively to glutamate receptors and preventing
stimulation from occurring [6, 20]. These have been shown to be partially effective in
animal models, but have not historically had great success in human trials [20]. It is
suspected that receptor antagonists may not be as effective in clinical scenarios, where
the trauma has already happened, and glutamate has already infiltrated and overwhelmed
the tissue [20].
The second potential therapy for excitotoxicity which is currently under research
are glutamate scavengers [21, 22]. The theory behind these drugs is that it is possible to
modulate glutamate levels in the CNS indirectly by manipulating glutamate levels in the
blood. Glutamate-pyruvate transaminase (GPT) and glutamate–oxaloacetate transaminase
(GOT), two blood resident glutamate scavenging enzymes, have both been tested for this
use in animal models, with positive outcomes [21, 22]. The treatment concept follows the
principle that glutamate will follow its concentration gradient. In cases of SCI, glutamate
levels in the blood and CNS, once separated by the BBB, come to an equilibrium which
allows the concentration of glutamate to build up in the brain. By introducing a blood
glutamate scavenger, glutamate levels are dramatically lowered in the blood, and CNS
glutamate follows its concentration gradient out of the CNS into the bloodstream,
relieving the damaged neural tissue from excitotoxic stimulation [21, 22].
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Current Research
Glutamate scavenging is a therapy that has been consistently shown to be
effective in animal models over the past several years [21-23]. The majority of new
publications on the subject are review articles stressing the need for future human trials
[21, 24, 25].
Secondary Injury Mechanism 6: Free radical damage
Mechanism
The final mechanism we will consider is damage resulting from tissue exposure to
reactive oxygen species (ROS) and reactive nitrogen species (RNS). Under normal
physiological conditions, these reactive species are produced in limited quantities to
enable essential reactions in the cell. These molecules include superoxide, hydroxyl
radical, and hydrogen peroxide, among others [26]. While these molecules are very
volatile and dangerous in high quantities, their production within the cell is limited to
only what is necessary for optimal function [26]. This is regulated by the mitochondria
and through the presence of various naturally-occurring antioxidant molecules and
enzymes [26].
In spinal cord injury states, however, these physiological safeguards are overrun,
causing an uncontrolled spike in ROS and RNS in the intracellular and extracellular
spaces [26]. It is suspected that the glutamate cascade and calcium ion influx described
above have a role to play in this, stimulating dysregulation of the mitochondria and
upregulating the generation of free radicals. Also contributing to this spike is increased
phagocyte activity; a byproduct of the neutrophils and macrophages that have infiltrated
the tissue in the absence of the BSCB. Finally, a third major source of these reactive
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species is tissue necrosis, which results in the uncontrolled dumping of lysosomal and
peroxisomal contents into the extracellular fluid [26]. Altogether, these sources, along
with a few other minor ones, combine to create an extracellular environment teeming
with ROS and RNS.
ROS and RNS are defined as having a much higher reactivity than their integral
element in its ground state. This characteristic makes them extremely volatile oxidizing
reagents. They have the ability to cause major oxidative damage and secondary proteasemediated damage to proteins and nucleic acids, with quite severe consequences; however,
they are especially devastating in their destruction of membrane lipids [6, 26-28]. They
accomplish lipid peroxidation by performing oxidation on a membrane lipid molecule
[6]. This electrostatic alteration causes instability and results in a chain reaction that
literally rips apart the membrane, ending in spontaneous cell death [6, 27]. ROS also can
act as intracellular messengers, causing direct activation of inflammatory and necrotic
pathways [6, 27]. The fatty acid composition of neuronal membranes leaves them
especially vulnerable to the deleterious effects of reactive oxidative species, and makes
these deadly molecules an especially important target in developing effective SCI
treatments [26].
Therapeutic Targets
The strategy behind mitigating free radical damage in SCI relies on the use of
antioxidants; which antioxidants to use and how to use them is not a simple thing to
determine, however. Z Jai, et al. (2012) lists several antioxidant compounds currently
under varying extents of investigation, including Cu,ZnSOD, vitamin E, 21aminosteroids (especially U-74006F), 3H-1,2-dithiole-3-thione, among many others [26].
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The goal is to supplement the body’s grossly overwhelmed natural antioxidant supply by
administering exogenous antioxidant throughout the critical window of time in which
oxidative stress is the most extreme.
Current Research
There are currently many researchers working on finding viable neuroprotective
antioxidant therapies. In one study, Wang Y, et al (2014) tested the antioxidant effects of
α-Lipoic acid-plus (LAP) using chelating intralysosomal iron as an oxidative reagent
[29]. The intent was to test LAP as a possible therapy for sub-arachnoid hemorrhage
(SAH), using rats as a model. They administered LA and LAP orally once a day for 72
hours [29]. Upon analyzing the results, they found that LA and LAP treatment was
correlated with significantly positive outcomes, including reduced cerebral edema and
BBB breakdown, lower incidence of cortical apoptosis, and less functional impairment
following the SAH [29].
Another study, performed by Zhang T, et al (2014), tested the neuroprotective
effects of ursolic acid (UA) in the same rat SAH model. Rats from each test group were
subjected to the injury, sacrificed after two days, and evaluated [30]. They found that the
UA treatment was associated with a significant reduction in early brain injury (EBI),
cerebral swelling, BBB breakdown, neural cell apoptosis, and neurological deficits [30].
Yet another study, Ohnishi M, et al (2012), explored the neuroprotective capacity
of another antioxidant, sesamin, specifically as a microglial inhibitor and MAP kinase
antagonist [31]. A rat intracerebral hemorrhage model was once again used [31]. The
sesamin therapy was successful at suppressing nitric oxide (NO) production and
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inhibiting p44/42 MAP kinase activation [31]. It also prevented the activation of
microglial cells in response to the hemorrhage [31].
A fourth study, conducted by Zhang X, et al (2014), investigated the
neuroprotective effects of the carotenoid, astaxanthin [32]. The researchers utilized a
SAH model in two different species, rats and rabbits [32]. The treatment was evaluated
using two modalities, intracerebroventricular injection and oral administration [32]. Not
only did the antioxidant perform well in virtually all of the parameters in which it was
tested, researchers observed that it actually upregulated the levels of endogenous
antioxidant in the rat model [32].
Overall, these studies only serve to underscore the immense potential that appears
to be associated with exogenous antioxidant therapies. As time goes on, further studies on
animal models will hopefully guide researchers to developing protocols for human trials.
A Comprehensive Approach: Multi-modal Therapy
Today, many researchers have come to see SCI trauma treatment as a complex
and multi-faceted undertaking [6, 33]. As discussed above, secondary spinal cord injury
is a phenomenon that comprises more than 20 individual pathological processes. It is not
a pathology that will respond optimally to a one-size fits all type of treatment. It is also
not a phenomenon that will be treated with maximum effectiveness by focusing on just
one or two of the specific, isolated elements of secondary injury at the exclusion of the
many others at work. It is a constellation of processes, and, as such, effective treatment
will increasingly entail a many-pronged approach that can be tailored to the individual
patient.
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Approaching secondary injury comprehensively and using a combination of
treatment modalities has the potential to promote a degree of therapeutic synergy, leading
to better overall outcomes than could be achieved with single-modality treatments alone.
As researchers continue to develop new, more effective strategies for approaching each
individual facet of the condition, treatment protocols will become increasingly more
elegant and efficacious. One day, we will hopefully be able to develop a treatment
protocol that addresses each aspect of the complexity in an individualized manner and
results in an optimization of qualitative outcome.
Other Current Fields of Research
The focus of this thesis is primarily on primary and secondary injury, with a
special focus on research that surrounds improving treatment of the latter. Before
concluding, it is worthwhile to mention some of the other areas of SCI treatment research
that are being pursued currently. In 2013, when the NIH originally released the
publication “Spinal Cord Injury: Hope through Research,” which has already been
referenced several times in this thesis, they listed four distinct categories into which the
general body of SCI research could be classified: neuroprotection, regeneration, cell
replacement, and retraining/plasticity [10]. Conceptually, these four categories represent
the four primary avenues of SCI treatment, as it is currently understood. Although this is
merely one classification scheme, it is a helpful one, and we will use it here to help make
more sense of the broad array of current research endeavors.
All of the research that we have discussed to this point falls under the category of
neuroprotection research. This describes the effort of finding ways to mitigate ongoing
neuronal damage following the initial insult by regulating secondary injury processes,

SPINAL CORD TRAUMA

25

ultimately promoting neuron sparing. As we have already discussed much of this research
at length, we will not take additional time to explore it here.
The second major focus category of research, regeneration, deals with the
regrowth and remyelination of severed axons through the site of the SCI lesion [10]. This
is a challenging outcome to achieve, as damaged neurons within the CNS are notorious
for their ineptitude at growing back in physiologically viable ways, assuming they ever
even grow back at all. With that being said, there have been a number of studies that have
seen some success in stimulating regeneration, however. For example, after SCI, a
number of proteins and cytokine molecules are upregulated at the site of the lesion, many
of which either directly or indirectly inhibit axonal growth [10]. One line of research has
been to look for pharmacological agents that can serve as antagonists to the action of
these growth inhibitors [10]. Numerous promising molecules have been identified [10].
Additionally, research has also been done to identify cellular pathways and neural growth
factors that can positively stimulate regeneration, as well. One study in 2015
demonstrated exceptional regeneration outcomes using the neurotrophic factor artemin
[34]. More recent research has demonstrated exciting potential in the activation of the
Wnt/β catenin signaling cascade [35 ,36]. This pathway is involved in embryogenesis and
has been shown to promote axonal regeneration in CNS trauma models, as well [35, 36].
Other studies have looked for ways to clear obstructive glial and myelin debris
from within the lesion using chondroitinases, which are specialized enzymes that degrade
proteoglycan elements. A bacterial enzyme, chondroitinase ABC I (cABC I), has
especially shown potential in this capacity [10]. Current research is now seeking out ways
to augment the enzyme’s stability so that it can be used more effectively in a therapeutic
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context [37, 38]. Additionally, researchers are also seeking out ways to incorporate
bioengineering in the field of axonal regeneration, through the use of axon bridge
elements, which are physical implements that are inserted into the site of the lesion to
essentially serve as scaffolding for the purpose of properly guiding and facilitating the
growth of newly developing axons [10]. These elements are often used in combination
with many of the pharmacological therapies described above [39, 40].
The third focus of research that the NIH report highlighted was that of cell
replacement. This is a vast area of research with many promising prospects [41]. One of
the chief focuses is that of stem cell research. The fundamental concept is that, by
transplanting pluripotent or multipotent cells into the injury site, healthy new nervous
tissue can be developed to fill the lesion zone. Any attempt to provide an adequate
discussion of current stem cell research in spinal cord injury would require its own paper,
and is thus far beyond the scope of this one, but for an excellent overview of the topic,
see the reviews by Oh and Jeon (2016) and Vismara, et al (2017) [42, 43]. One of the
major challenges still facing researchers in this field is the puzzle of determining the
identity and influence of the many neurotropic growth factors that play into normal
nervous system differentiation and development [10]. A deeper understanding of these
processes will be necessary in order to maximize therapeutic benefits in the future.
The fourth and final area of research is in the field of plasticity and retraining the
surviving neurons in the post-trauma CNS to take on functionalities that were initially
lost due to the injury. Equally notable as the CNS’s inability to grow back significant
amounts of new tissue is its incredible ability to repurpose existing, intact tissue in
adaptive ways. Researchers continue to explore ways to harness this capability to help
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provide some degree of restoration in motor and sensory function in incomplete SCI
cases [10]. Additionally, recent research has also sought to assess the health benefits of
exercise on SCI patients, who often become more vulnerable to morbidities such as
obesity and cardiovascular disease following their injury, due to a more sedentary
lifestyle, on average [10]. For a good survey of research findings on this topic, see the
recent article by van der Scheer, et al, in Neurology [44].
Beyond this, much is being done in the ever-advancing field of technology-based
therapies, such as electrical stimulation techniques and robotic-assisted therapy [10]. As
these technologies continue to emerge and develop, there is hope that they will one day
allow us to bypass the lesion site entirely and restore function to paralyzed regions of the
body via biotechnological interfaces [10].
Conclusion
In conclusion, the structures of the spinal cord and vertebral column are truly a
masterpiece of design. Every element is constructed from the inside out to provide an
optimal balance of protection and mobility. When trauma occurs that overcomes these
defenses, it sets into motion a constellation of physiological responses that exacerbate the
severity and accelerate the expansion of the spinal cord lesion. These secondary
mechanisms of injury cause latent functional losses and can worsen the prognosis in
many spinal trauma cases.
However, while secondary injury does present major challenges in the effective
management of spinal cord injury, it also presents great opportunity. Whereas there is
typically no opportunity for clinical intervention to mitigate primary injury, past and
current research suggests that we are merely scratching the surface in our ability to take
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full advantage of opportunities to treat secondary injury. This means that we are currently
not achieving optimal outcomes in the majority of spinal trauma cases—there is
enormous room for growth in this field. While virtually all other areas of current SCIrelated research deal with going back and repairing the damage incurred throughout the
early-to-middle injury processes, secondary injury therapy has, perhaps more than
anything else, the potential to substantially limit the amount of damage incurred in the
first place. In light of this, we have a responsibility, both to learn more about the
mechanisms contributing to secondary SCI and to become better equipped at managing it
strategically and effectively, thereby bringing about qualitatively more optimal outcomes.
Additionally, the fact that secondary injury is so complex and multi-faceted
presents a remarkable opportunity, because it gives us the ability to approach treatment in
many different ways. A breakthrough in our understanding of any one of these facets has
the potential to revolutionize how we conceive of and treat SCI.
For millennia, spinal cord injury has been a grave condition. Where it has not
taken life, it has invariably stolen away quality of life, leaving its survivors with physical
disability, psychological and emotional pain, and economic dependency. Now, finally,
we may actually be on the cusp of a paradigm shift where secondary spinal injury can be
managed in such a way as to bring about more favorable prognoses than ever before.
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